Funder: British Heart Foundation
Due Dates: February 4, 2026 (Preliminary, first intake) | August 5, 2026 (Preliminary, second intake)
Funding Amounts: No set limit; awards typically up to 3 years, with budgets justified by project scope.
Summary: Supports innovative cardiovascular technologies from proof-of-concept to market readiness, emphasizing strong IP and commercialisation strategies.
Key Information: Preliminary application required; full application by invitation only.